Dyadic-Based Diagnosis, Care, and Prevention for HIV Discordant Couples in Tanzania
NCT ID: NCT03098693
Last Updated: 2022-02-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
128 participants
OBSERVATIONAL
2017-11-21
2020-09-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Enhanced HIV Prevention in Couples: Feasibility Study #3
NCT02027519
Impact of Integrated HIV/NCD Screening on HIV Testing Uptake and Engagement in HIV Care in Kisarawe, Tanzania
NCT03098654
Partners-based HIV Treatment for Couples Attending Antenatal Care
NCT03149237
Enhanced Prevention in Couples: Feasibility Study #2
NCT02027441
Implementing a Comprehensive Prevention of Mother-to-Child Transmission of HIV Program for South African Couples
NCT02085356
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The specific AIMS evaluate 4 key strategic goals, including:
1. HIV Self-Testing for Stable Couples: (a) assess the acceptability, safety, and factors associated with uptake of HIV self-testing; and (b) determine the proportion of clients testing positive for HIV via self-testing who engage in care.
2. Dyadic Engagement of Sero-Discordant Couples in Care \& Prevention: (a) establish the proportion of sero-discordant couples who will enroll in HIV care as a dyad, (b) determine the effect of dyadic care enrollment on HIV care retention and ART adherence, and (c) assess reduction in risk of acquiring HIV infection for the negative partner.
3. Pre-Exposure Prophylaxis (PrEP): (a) establish the proportion and characteristics of HIV negative clients in a sero-discordant relationship who opt to take PrEP, (b) determine how engaging in ARV treatment by the positive partner affects PrEP utilization by the negative partner, and vice versa, and (c) Identify patterns and correlates of risk reduction strategies that couples in care utilize over time (abstinence, ARV for positive partner, PrEP for negative partner, condom use).
4. Operational: (a) determine Dyadic-based Diagnosis, Care, \& Prevention (DDCP) program cost and economic efficiency, (b) compare DDCP to clinic-based and mobile VCT with regard to cost and efficiency for testing and linkage to care, and (c) assess the feasibility, acceptability, safety, and utility of using biometric data to track service utilization.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sero-discordant Couple Cohort
We will enroll and track a cohort of 60 serodiscordant couples (120 individuals). The HIV-positive couple members will be offered anti-retroviral therapy (ART) and the HIV-negative couple members will be offered pre-exposure prophylaxis (PrEP). We will monitor monthly clinic visits for the couple and will conduct in-depth behavioral surveys at baseline, 6-, 12-, and 18-months.
HIV Self-Testing
Access to home-based HIV self-testing kits for stable couples.
Immediate Access to ART for HIV infected couple members
Immediate access to ART for HIV infected couple members (per current Tanzanian standard of care).
Access to PrEP for HIV uninfected couple members
Access to PrEP for HIV uninfected couple members.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HIV Self-Testing
Access to home-based HIV self-testing kits for stable couples.
Immediate Access to ART for HIV infected couple members
Immediate access to ART for HIV infected couple members (per current Tanzanian standard of care).
Access to PrEP for HIV uninfected couple members
Access to PrEP for HIV uninfected couple members.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. age 18 years or older (and at least one member of the couple has to be aged 55 years or below),
2. live in the household regularly,
3. have no plans for moving from the area before the follow up period.
To be eligible for the prevention and care portion of the study, couples must be:
1. in an HIV sero-discordant relationship,
2. pregnant or breastfeeding women will be allowed to enroll in the study after counseling on the risks and benefits is provided,
3. HIV-negative women who are pregnant or breastfeeding will be allowed to take PrEP after counseling on the risks and benefits is provided.
Exclusion Criteria
1. the HIV-negative member has signs of advanced kidney disease (measured by serum creatinine),
2. the HIV-negative partner has Hepatitis B and markers of poor liver functioning (measured by alanine aminotransferase).
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
Medical University of South Carolina
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Sweat
Professor, Director, Division of Global and Community Health, Director of MUSC Center for Global Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Muhimbili University of Health and Allied Programs
Dar Es Salaam, Coast Region, Tanzania
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.